Kuros Biosciences AG (SWX:KURN)
Switzerland · Delayed Price · Currency is CHF 22.90
+0.40 (1.78%)
Aug 4, 2026, 12:53 PM CET
Kuros Biosciences AG Stock Forecast
Stock Price Forecast
According to 4 analysts polled by S&P Global, Kuros Biosciences AG stock has a consensus rating of "Strong Buy" and an average price target of CHF 33.86. The average 1-year stock price forecast is 47.86% higher than the current stock price, while the lowest is CHF 32.00 (+39.74%) and the highest is CHF 38.00 (+65.94%).
Price Target: CHF 33.86 (+47.86%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Kuros Biosciences AG stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | May '26 | Jun '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 3 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 2 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| UBS | UBS | Buy Maintains CHF 33.00 | Buy | Maintains | CHF 33.00 | +44.10% | Jul 29, 2026 |
| Berenberg Bank | Berenberg Bank | Buy Initiates CHF 32.00 | Buy | Initiates | CHF 32.00 | +39.74% | Jul 8, 2026 |
| Kepler Capital | Kepler Capital | Buy Maintains CHF 38.00 | Buy | Maintains | CHF 38.00 | +65.94% | Apr 14, 2026 |
Financial Forecast
Revenue This Year
213.35M
from 146.06M
Increased by 46.07%
Revenue Next Year
286.81M
from 213.35M
Increased by 34.43%
EPS This Year
0.29
from 0.06
Increased by 379.56%
EPS Next Year
0.66
from 0.29
Increased by 128.59%
EPS and Forward PE are based on non-GAAP adjusted numbers.